These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7977699)

  • 41. Gating properties of heterotypic gap junction channels formed of connexins 40, 43, and 45.
    Rackauskas M; Kreuzberg MM; Pranevicius M; Willecke K; Verselis VK; Bukauskas FF
    Biophys J; 2007 Mar; 92(6):1952-65. PubMed ID: 17189315
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is the junctional uncoupling elicited in rat ventricular myocytes by some dephosphorylation treatments due to changes in the phosphorylation status of Cx43?
    Hervé JC; Plaisance I; Loncarek J; Duthe F; Sarrouilhe D
    Eur Biophys J; 2004 May; 33(3):201-10. PubMed ID: 14745523
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro optimization of antisense oligodeoxynucleotide design: an example using the connexin gene family.
    Law LY; Zhang WV; Stott NS; Becker DL; Green CR
    J Biomol Tech; 2006 Sep; 17(4):270-82. PubMed ID: 17028167
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Subchronic alpha- and beta-adrenergic regulation of cardiac gap junction protein expression.
    Salameh A; Frenzel C; Boldt A; Rassler B; Glawe I; Schulte J; Mühlberg K; Zimmer HG; Pfeiffer D; Dhein S
    FASEB J; 2006 Feb; 20(2):365-7. PubMed ID: 16352648
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of connexin 37, 40, and 43 mRNA and protein in renal preglomerular arterioles.
    Arensbak B; Mikkelsen HB; Gustafsson F; Christensen T; Holstein-Rathlou NH
    Histochem Cell Biol; 2001 Jun; 115(6):479-87. PubMed ID: 11455448
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intercellular communication in cultured human vascular smooth muscle cells.
    Wang HZ; Day N; Valcic M; Hsieh K; Serels S; Brink PR; Christ GJ
    Am J Physiol Cell Physiol; 2001 Jul; 281(1):C75-88. PubMed ID: 11401829
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Connexin mediates gap junction-independent resistance to cellular injury.
    Lin JH; Yang J; Liu S; Takano T; Wang X; Gao Q; Willecke K; Nedergaard M
    J Neurosci; 2003 Jan; 23(2):430-41. PubMed ID: 12533603
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Connexin mimetic peptides fail to inhibit vascular conducted calcium responses in renal arterioles.
    Sorensen CM; Salomonsson M; Braunstein TH; Nielsen MS; Holstein-Rathlou NH
    Am J Physiol Regul Integr Comp Physiol; 2008 Sep; 295(3):R840-7. PubMed ID: 18614765
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multiple connexins confer distinct regulatory and conductance properties of gap junctions in developing heart.
    Veenstra RD; Wang HZ; Westphale EM; Beyer EC
    Circ Res; 1992 Nov; 71(5):1277-83. PubMed ID: 1382884
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biological and biophysical properties of vascular connexin channels.
    Johnstone S; Isakson B; Locke D
    Int Rev Cell Mol Biol; 2009; 278():69-118. PubMed ID: 19815177
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gap junction channel activity in cultured human bladder smooth muscle cell pairs: gating and unitary conductances.
    Wang HZ; Lee SW; Day NS; Christ GJ
    Urology; 2001 Jun; 57(6 Suppl 1):111. PubMed ID: 11378079
    [No Abstract]   [Full Text] [Related]  

  • 52. The role of gap junction membrane channels in development.
    Lo CW
    J Bioenerg Biomembr; 1996 Aug; 28(4):379-85. PubMed ID: 8844335
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Connexin genes and cell growth control.
    Yamasaki H; Krutovskikh V; Mesnil M; Omori Y
    Arch Toxicol Suppl; 1996; 18():105-14. PubMed ID: 8678786
    [No Abstract]   [Full Text] [Related]  

  • 54. Gap junction permeability is diminished in proliferating vascular smooth muscle cells.
    Kurjiaka DT; Steele TD; Olsen MV; Burt JM
    Am J Physiol; 1998 Dec; 275(6):C1674-82. PubMed ID: 9843730
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dominant inhibition of intercellular communication by two chimeric connexins.
    Goliger JA; Bruzzone R; White TW; Paul DL
    Clin Exp Pharmacol Physiol; 1996 Dec; 23(12):1062-7. PubMed ID: 8977161
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Spatiotemporal depletion of connexins using antisense oligonucleotides.
    Green CR; Law LY; Lin JS; Becker DL
    Methods Mol Biol; 2001; 154():175-85. PubMed ID: 11218648
    [No Abstract]   [Full Text] [Related]  

  • 57. Applications of antisense oligodeoxynucleotides in virology.
    Malcolm AD; Coulson J; Blake N; Archard LC
    Biochem Soc Trans; 1992 Nov; 20(4):762-4. PubMed ID: 1487059
    [No Abstract]   [Full Text] [Related]  

  • 58. Chronic kidney disease: Targeting connexin-43 reduces progression of CKD in mice.
    Sidaway P
    Nat Rev Nephrol; 2014 Aug; 10(8):424. PubMed ID: 24914584
    [No Abstract]   [Full Text] [Related]  

  • 59. Structural basis of connexin-36 gap junction channel inhibition.
    Ding X; Aureli S; Vaithia A; Lavriha P; Schuster D; Khanppnavar B; Li X; Blum TB; Picotti P; Gervasio FL; Korkhov VM
    Cell Discov; 2024 Jun; 10(1):68. PubMed ID: 38890333
    [No Abstract]   [Full Text] [Related]  

  • 60. Gap Junction Blockers: An Overview of their Effects on Induced Seizures in Animal Models.
    Manjarrez-Marmolejo J; Franco-Pérez J
    Curr Neuropharmacol; 2016; 14(7):759-71. PubMed ID: 27262601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.